STERIS (STE) Competitors

$232.69
+1.96 (+0.85%)
(As of 05/17/2024 ET)

STE vs. EW, ZBH, ALGN, SNN, CAH, BNTX, PHG, WAT, ARGX, and WST

Should you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Align Technology (ALGN), Smith & Nephew (SNN), Cardinal Health (CAH), BioNTech (BNTX), Koninklijke Philips (PHG), Waters (WAT), argenx (ARGX), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector.

STERIS vs.

STERIS (NYSE:STE) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Edwards Lifesciences received 987 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 71.82% of users gave Edwards Lifesciences an outperform vote while only 58.51% of users gave STERIS an outperform vote.

CompanyUnderperformOutperform
STERISOutperform Votes
323
58.51%
Underperform Votes
229
41.49%
Edwards LifesciencesOutperform Votes
1310
71.82%
Underperform Votes
514
28.18%

STERIS has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.

Edwards Lifesciences has a net margin of 23.01% compared to STERIS's net margin of 6.95%. Edwards Lifesciences' return on equity of 22.86% beat STERIS's return on equity.

Company Net Margins Return on Equity Return on Assets
STERIS6.95% 13.73% 7.73%
Edwards Lifesciences 23.01%22.86%16.52%

Edwards Lifesciences has higher revenue and earnings than STERIS. Edwards Lifesciences is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STERIS$5.14B4.47$378.24M$3.8260.91
Edwards Lifesciences$6.00B8.95$1.40B$2.3238.42

94.7% of STERIS shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 1.0% of STERIS shares are owned by insiders. Comparatively, 1.3% of Edwards Lifesciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Edwards Lifesciences had 2 more articles in the media than STERIS. MarketBeat recorded 19 mentions for Edwards Lifesciences and 17 mentions for STERIS. STERIS's average media sentiment score of 0.77 beat Edwards Lifesciences' score of 0.77 indicating that STERIS is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STERIS
10 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Edwards Lifesciences
9 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

STERIS currently has a consensus price target of $241.60, suggesting a potential upside of 3.83%. Edwards Lifesciences has a consensus price target of $93.88, suggesting a potential upside of 5.31%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, analysts clearly believe Edwards Lifesciences is more favorable than STERIS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STERIS
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Edwards Lifesciences
1 Sell rating(s)
6 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.58

Summary

Edwards Lifesciences beats STERIS on 14 of the 18 factors compared between the two stocks.

Get STERIS News Delivered to You Automatically

Sign up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STE vs. The Competition

MetricSTERISSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$22.99B$9.39B$5.35B$18.08B
Dividend Yield0.89%1.35%44.08%3.44%
P/E Ratio60.9113.41106.3122.53
Price / Sales4.4743.552,361.3010.30
Price / Cash23.6222.1636.8819.48
Price / Book3.644.365.496.01
Net Income$378.24M$189.08M$108.83M$966.65M
7 Day Performance0.59%2.09%1.42%1.85%
1 Month Performance16.57%4.53%4.96%6.59%
1 Year Performance13.12%-12.87%7.85%23.69%

STERIS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EW
Edwards Lifesciences
4.4984 of 5 stars
$86.46
+2.1%
$93.27
+7.9%
+2.0%$52.10B$6.14B37.2719,800Analyst Upgrade
ZBH
Zimmer Biomet
4.8386 of 5 stars
$119.97
+0.3%
$135.40
+12.9%
-11.0%$24.68B$7.39B25.9718,000Dividend Announcement
Analyst Forecast
ALGN
Align Technology
4.9943 of 5 stars
$278.08
+2.0%
$353.00
+26.9%
-7.5%$20.93B$3.86B45.8121,610Short Interest ↓
Positive News
SNN
Smith & Nephew
1.6885 of 5 stars
$25.77
+2.6%
N/A-18.7%$11.26B$5.55B0.0018,452Positive News
CAH
Cardinal Health
4.627 of 5 stars
$97.41
-0.6%
$107.00
+9.8%
+15.8%$23.73B$205.01B43.2948,000Analyst Forecast
BNTX
BioNTech
1.4639 of 5 stars
$92.28
-0.5%
$118.82
+28.8%
-13.7%$21.94B$4.13B184.566,133Analyst Forecast
Short Interest ↑
PHG
Koninklijke Philips
1.5019 of 5 stars
$26.97
flat
N/A+37.2%$25.04B$19.66B-28.0969,656Analyst Downgrade
WAT
Waters
3.4648 of 5 stars
$358.99
+2.8%
$305.78
-14.8%
+32.8%$21.30B$2.96B35.237,900Insider Selling
News Coverage
ARGX
argenx
2.9598 of 5 stars
$356.01
-1.0%
$524.68
+47.4%
-11.5%$21.16B$1.27B-62.901,148Earnings Report
Short Interest ↑
WST
West Pharmaceutical Services
4.8631 of 5 stars
$354.48
-1.0%
$435.20
+22.8%
+1.4%$25.82B$2.95B46.7710,600Analyst Revision

Related Companies and Tools

This page (NYSE:STE) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners